A Study With LY293111, Gemcitabine and Placebo in Patients With Pancreatic Cancer
Clinical trial NCT00055250 · COMPLETED
Trial details
- NCT number
- NCT00055250
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2003-01-01
- Enrollment
- 130
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.